Sonam Bhatia

Employment

• Dana-Farber Cancer Institute Associate Director, Center for Patient Derived Models
  2022 - Present
• Cold Spring Harbor Laboratory
  2017 - 2022

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (33)

• Supplementary Figure Legends from LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer
  2026 DOI: 10.1158/1541-7786.32742717
  +Save
• Supplementary Figure S1 from LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer
  2026 DOI: 10.1158/1541-7786.32742714
  +Save
• Supplementary Figure S2 from LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer
  2026 DOI: 10.1158/1541-7786.32742711
  +Save
• Supplementary Table S1 from LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer
  2026 DOI: 10.1158/1541-7786.32742708
  +Save
• Supplementary Table S2 from LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer
  2026 DOI: 10.1158/1541-7786.32742705
  +Save
• Supplementary Table S3 from LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer
  2026 DOI: 10.1158/1541-7786.32742702
  +Save
• Supplementary Table S4 from LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer
  2026 DOI: 10.1158/1541-7786.32742699
  +Save
• Supplementary Table S5 from LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer
  2026 DOI: 10.1158/1541-7786.32742696
  +Save
• Data from LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer
  2026 DOI: 10.1158/1541-7786.c.8547651
  +Save
• LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer
  Molecular Cancer Research 2025 DOI: 10.1158/1541-7786.MCR-24-1143
  +Save